Abstract
The Asia Pacific dental BGS and tissue regeneration market is expected to
generate over $18 million over the next five years. Comprising Australia,
Japan, and South Korea, the Asia Pacific market for dental bone graft
substitutes (BGS) and tissue regeneration has experienced significant growth.